Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2014 08:30 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Announces Upcoming Presentations on ITI-007 at the American Psychiatric Association 167th Annual Meeting, the Society of Biological Psychiatry 69th Annual Meeting, and the International Review of Psychosis & Bipolarity Annual Meeting

NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
April 07, 2014 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Announces Multiple Presentations on ITI-007 at the 4th Biennial Schizophrenia International Research Society (SIRS) Conference

NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
April 02, 2014 11:20 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Announces Upcoming Presentations at the 4th Biennial Schizophrenia International Research Society Conference

NEW YORK, April 2, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
March 25, 2014 16:01 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2013 Financial Results

NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...